Sign in
CompletedNo phase

Comparison of Clinical Outcomes in Ziemer Femtosecond Versus Conventional Phacoemulsification Surgery

Key facts

Who runs it
Singapore Eye Research Institute
Where
Singapore1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
13 people enrolled
Started
Aug 2015
Ended
28 Feb 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Femtosecond laser assisted cataract surgery
  • Conventional phacoemulsification
Record updated
29 May 2025

Who can take part

Age
55 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 21 criteriaShow less

Who can take part

  • A cataract will be defined as clouding of the lens that interferes with normal vision
  • Not relevant, as study not on cancer patients
  • Only patients older than 50 years will be included, as cataracts develops with increasing age. No gender criteria are applied
  • Only individuals with the mental capacity to provide informed consent with be included; More specifically, all the following inclusion criteria must be met:
  • Patients have medically dilated pupil size of at least 4.0mm
  • Patients are willing and able to sign a written Informed Consent Form prior to any study-specific procedures
  • Patients are willing and able to return for scheduled follow-up examinations for 12 months after the cataract surgery

Who cannot take part

  • Patients with prior history of pseudoexfoliation syndrome
  • Patients with a prior history of glaucoma filtration surgery
  • Patients with a prior history of vitrectomy
  • Patients with a prior history of cataract or refractive lens surgery
  • Patients with ocular pathology or disease (including pupil pathology such as fixated pupils) that might confound the outcome or increase the risk of adverse event
  • Patients with residual, recurrent, active or uncontrolled eyelid disease
  • Patients with any progressive retinal disease or subjects with a history or evidence of retinal vascular occlusion and/or hypercoagulability, because of the risks associated with high pressures during suction application
  • Patients who are pregnant, lactating, of child-bearing potential and not practising a medically approved method of birth control, or planning to become pregnant during the course of the trial, and patients with other conditions associated with fluctuation of hormones that could lead to refractive changes
  • Patients with optic atrophy
  • Patients with central corneal scarring
  • Patients with significant corneal asymmetry or irregular topography
  • Patients with anterior segment pathology
  • Patients with any corneal abnormality
  • Patients with amblyopia or strabismus or those who are at risk for developing strabismus postoperatively as determined by corneal light reflex and cover-uncover testing

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study is aimed to compare the clinical outcomes in Ziemer LDV Z8 femtosecond laser-assisted cataract surgery versus conventional phacoemulsification cataract surgery

The 2 groups in the trial

  • ConventionalPlacebo, for comparison

    Conventional phacoemulsification surgery

    Treatment: Conventional phacoemulsification

  • Femtosecond laserExisting treatment, for comparison

    Ziemer femtosecond laser assisted cataract surgery Intervention: Ziemer femtosecond laser assisted cataract surgery

    Treatment: Femtosecond laser assisted cataract surgery

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Comparison of Clinical Outcomes in Ziemer LDV Z8 Femtosecond Laser-assisted Cataract Surgery
Record updated
29 May 2025